STOCK TITAN

Cyclacel Pharmaceuticals 6% Cnvrtbl. Prfrd. Stock (CYCCP) EPS by Year

CYCCP

Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock lost $6.45 per diluted share in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock has filed alongside them.

FY2025 annual
EPS (Diluted) -$6.45
YoY n/m
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CYCCP EPS (Diluted) by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
EPS (Diluted)-$6.45n/m-$502.46-$6.42-$27.24-$2.09-$3.42N/AN/AN/AN/AN/AN/AN/AN/AN/A

CYCCP EPS (Diluted) by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-Q
EPS (Diluted)-$0.04N/A-$1.31-$0.98$0.00n/mN/A-$43.80-$172.18-$2.27N/AN/A-$0.44n/m

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock financials

Frequently Asked Questions

Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock lost $6.45 per diluted share in fiscal year 2025.

Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock (CYCCP) reported a loss of $502.46 per diluted share in fiscal year 2024 and a loss of $6.45 per diluted share in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.

Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock (CYCCP) reported -$0.04 in diluted earnings per share in Q1 2026.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock (CYCCP) reported on that line in every period on record.